Inlyta (axitinib)

pCPA File Number: 20768
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Renal Cell Carcinoma
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
pCODR 10013
pCPA Engagement Letter Issued:
Negotiation Process Concluded: